Vivos Therapeutics, Inc. · NASDAQ:VVOS
Streeterville Capital LLC's stake in Vivos Therapeutics, Inc. fell to 0.60% (Schedule 13G/A)
Event Sep 3, 2026 · Filed Sep 3, 2026
Streeterville Capital LLC's stake in Vivos Therapeutics, Inc. fell to 0.60%, 122,963 shares, as a passive investor on Sep 3, 2026. Filed Sep 3, 2026 (Schedule 13G/A).
- Stake
- 0.60%
- Shares
- 122,963
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Streeterville Capital LLC | 0.60% | 122,963 |
| Streeterville Management, LLC | 0.60% | 122,963 |
| John M Fife | 0.60% | 122,963 |
Source
Related
- Vivos Therapeutics, Inc.
- Streeterville Capital LLC
- Vivos Therapeutics, Inc. shareholders
- Schedule 13G · Streeterville Capital LLC · Aug 11, 2026
- Form 4 · Huntsman Ronald Kirk · Sep 18, 2026
- Form 4 · Amman Bradford K. · Aug 26, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13D · V-Co Investors 4 LLC · Jul 15, 2026
- Schedule 13G · Armistice Capital, LLC · May 15, 2026